116 related articles for article (PubMed ID: 25103124)
1. Capsule commentary on Romanelli et al., predictors of statin compliance after switching from branded to generic agents among managed-care beneficiaries.
Pathak H
J Gen Intern Med; 2014 Oct; 29(10):1391. PubMed ID: 25103124
[No Abstract] [Full Text] [Related]
2. Predictors of statin compliance after switching from branded to generic agents among managed-care beneficiaries.
Romanelli RJ; Segal JB
J Gen Intern Med; 2014 Oct; 29(10):1372-8. PubMed ID: 24957381
[TBL] [Abstract][Full Text] [Related]
3. Compliance after switching from branded to generic statins.
Romanelli RJ; Jukes T; Segal JB
Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1093-100. PubMed ID: 24817435
[TBL] [Abstract][Full Text] [Related]
4. Generic and therapeutic statin switches and disruptions in therapy.
Chapman RH; Benner JS; Girase P; Benigno M; Axelsen K; Liu LZ; Nichol MB
Curr Med Res Opin; 2009 May; 25(5):1247-60. PubMed ID: 19344292
[TBL] [Abstract][Full Text] [Related]
5. Better outcomes with generic statins.
Harv Heart Lett; 2014 Dec; 25(4):8. PubMed ID: 26094262
[No Abstract] [Full Text] [Related]
6. Switching, Discontinuation, and Reinitiation of Statins Among Older Adults.
Ofori-Asenso R; Ilomaki J; Tacey M; Zomer E; Curtis AJ; Si S; Zullo AR; Korhonen MJ; Bell JS; Zoungas S; Liew D
J Am Coll Cardiol; 2018 Nov; 72(21):2675-2677. PubMed ID: 30466527
[No Abstract] [Full Text] [Related]
7. Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland.
Helin-Salmivaara A; Korhonen MJ; Alanen T; Huupponen R
J Clin Pharm Ther; 2012 Feb; 37(1):58-64. PubMed ID: 21410736
[TBL] [Abstract][Full Text] [Related]
8. Patient co-payment and adherence to statins: a review and case studies.
Simoens S; Sinnaeve PR
Cardiovasc Drugs Ther; 2014 Feb; 28(1):99-109. PubMed ID: 24150747
[TBL] [Abstract][Full Text] [Related]
9. Generic medicines in Pakistan: a viable cost-effective option for consumers.
Jamshed SQ; Ibrahim MI; Shafie AA; Hassali MA; Babar Z
Eur J Clin Pharmacol; 2011 Sep; 67(9):969-70. PubMed ID: 21445637
[No Abstract] [Full Text] [Related]
10. Effects of generic substitution on refill adherence to statin therapy: a nationwide population-based study.
Trusell H; Sundell KA
BMC Health Serv Res; 2014 Dec; 14():626. PubMed ID: 25475416
[TBL] [Abstract][Full Text] [Related]
11. To switch (statins) or not to switch? That is the question.
Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
Expert Opin Pharmacother; 2010 Dec; 11(18):2943-6. PubMed ID: 20958109
[TBL] [Abstract][Full Text] [Related]
12. Clinical review: impact of statin substitution policies on patient outcomes.
Atar D; Carmena R; Clemmensen P; K-Laflamme A; Wassmann S; Lansberg P; Hobbs R
Ann Med; 2009; 41(4):242-56. PubMed ID: 19191052
[TBL] [Abstract][Full Text] [Related]
13. Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway.
Håkonsen H; Toverud EL
Eur J Clin Pharmacol; 2011 Feb; 67(2):193-201. PubMed ID: 21161197
[TBL] [Abstract][Full Text] [Related]
14. Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.
Kwong WJ; Kamat S; Fang C
Ann Pharmacother; 2012 Dec; 46(12):1609-16. PubMed ID: 23150608
[TBL] [Abstract][Full Text] [Related]
15. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
Sedjo RL; Cox ER
Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
[TBL] [Abstract][Full Text] [Related]
16. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic dose assessment of patient switching from atorvastatin to simvastatin.
Hess G; Sanders KN; Hill J; Liu LZ
Am J Manag Care; 2007 Jun; 13 Suppl 3():S80-5. PubMed ID: 17596116
[TBL] [Abstract][Full Text] [Related]
18. Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a 'real-world' retrospective cohort study.
Degli Esposti L; Sangiorgi D; Buda S; Degli Esposti E; Scaglione F
BMJ Open; 2016 Nov; 6(11):e012003. PubMed ID: 27807083
[TBL] [Abstract][Full Text] [Related]
19. Capsule Commentary on Marcum et al., Statin Dosing Instructions, Medication Adherence, and Low-Density Lipoprotein Cholesterol: a Cohort Study of Incident Statin Users.
O'Connor PJ
J Gen Intern Med; 2019 Nov; 34(11):2585. PubMed ID: 31482342
[No Abstract] [Full Text] [Related]
20. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.
Wong MC; Wang HH; Liu KS
Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
